Epidemiology of Malaria in Ubon Ratchathani, Thailand
NCT02991963 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660
Last updated 2017-01-20
Summary
This is an observational study (case-control study) aiming to identify risk factors for malaria infection in health centers or malaria posts or district hospitals in Buntharik District and Nachalui District, Ubon Ratchathani Province, Thailand.
This study expects to recruit 330 cases (malaria positive) and 330 control (negative cases) subject. One-to-one matching of cases (malaria positive) and controls (malaria negative) will be done at each study site.
CASE (Malaria positive) subject will go through the following;
1. Enrollment visit (Day 0)
1.1 Blood collection of three dried blood spots, and malaria slide. In district hospitals in individuals \>14 kg: additional 10ml venous blood will be collected.
1.2 A survey questionnaire which includes patient demographics, information on malaria treatment, bed net use and possible risk factors for acquiring malaria, as well as questions about their travel and usage of mobile phones will be administered.
2. Follow up visits (if fever plus Day 42 (+/-3))
2.1 Blood collection of three dried blood spots and malaria slide. In district hospitals: additional 0.5ml venous blood will be collected.
2.2 Short survey questionnaire including questions on symptoms, travel and possible risk behaviors since enrollment will be administered.
CONTROL (Malaria negative) subject will go through the following;
1. Enrollment visit (Day 0)
1.1 Blood collection to confirm negative malaria slide. In district hospitals: additional 0.5ml venous blood will be collected.
1.2 A survey questionnaire including patient demographics, information on any recent malaria treatment they may have taken, bed net use and possible risk factors for acquiring malaria, as well as questions about their travel and usage of mobile phones will be administered.
2. Follow up visit: No follow up visit
Conditions
- Epidemiology
Interventions
- OTHER
-
Interview
A survey will be included patient demographics, information on malaria treatment, bed net use and possible risk factors for acquiring malaria, as well as questions about their travel and usage of mobile phones
- OTHER
-
Blood collection (Dried Blood Spot)
Dried Blood Spot
- OTHER
-
Blood Collection (Venous Blood collection)
Venous Blood collection
- OTHER
-
Blood Smear
Slide blood smear
Sponsors & Collaborators
-
Mahidol Oxford Tropical Medicine Research Unit
collaborator OTHER -
University of Oxford
lead OTHER
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Mass Screening and Treatment for Reduction of Falciparum Malaria
NCT04093765 ·Status: COMPLETED ·Phase: NA
-
Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
NCT05052502 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers
NCT02427360 ·Status: COMPLETED
-
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
NCT01228344 ·Status: COMPLETED
-
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
NCT03783299 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence Survey of Antimalarial Drug Resistance Markers
NCT03217851 ·Status: COMPLETED
-
A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes
NCT05071079 ·Status: RECRUITING ·Phase: NA
-
Trial of Malaria Seasonal IPTc Combined With Community Case Management
NCT01449045 ·Status: COMPLETED ·Phase: PHASE3
-
Ethiopia Malaria Therapeutic Efficacy Study
NCT01052584 ·Status: COMPLETED ·Phase: NA
-
Targeted Chemo-elimination (TCE) of Malaria
NCT01872702 ·Status: COMPLETED ·Phase: NA
-
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
NCT05041556 ·Status: RECRUITING
-
Epidemiology Study of Malaria Transmission Intensity in Africa
NCT01190202 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria
NCT00709969 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda
NCT04037332 ·Status: COMPLETED
-
Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand
NCT01659281 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.
NCT02089841 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria High-Risk Populations in Namibia
NCT04094727 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial on Supervised Primaquine Use in Ethiopia
NCT02793388 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia
NCT06300970 ·Status: COMPLETED ·Phase: PHASE4
-
Cohort Event Monitoring in Sub Saharan Africa
NCT02817919 ·Status: COMPLETED
-
Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)
NCT04041973 ·Status: COMPLETED ·Phase: NA
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567 ·Status: UNKNOWN ·Phase: NA
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Antimalarial Drug Resistance in Mali
NCT00127998 ·Status: COMPLETED ·Phase: NA